Blog - Rice is a crucial staple food for about half a billion people in Asia, but it suffers from diseases that reduce yields, destroy harvests and put food security and livelihoods at risk. But there is hope – by tracking DNA markers of natural genetic variants through generations of crosses, breeders can identify better combinations that enrich crop vitality and resilience leading to more reliable and sustainable rice production.
30 July 2018News - LGC has today announced a further strengthening of its nucleic acid chemistry (NAC) offering with the acquisition of Berry and Associates, premier supplier of specialty oligo reagents.
27 September 2018News - LGC announced today that Dr Julian Braybrook has been appointed the UK Government Chemist. He replaces Dr Derek Craston, who completed two terms of five years each in this Office.
01 June 2018News - LGC has today announced a further strengthening of its nucleic acid chemistry (NAC) offering with the acquisition of BioAutomation Corporation (BioAutomation), manufacturer of the renowned MerMade oligo synthesis instruments.
01 May 2018News - Lucigen offers extensive enzymology expertise and a wide portfolio of molecular biology reagents
16 February 2018News - LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.
18 October 2018News - Exclusive license agreement relates to use of CoPrimer™ technology for both research and commercial applications.
31 October 2018News - Strengthens LGC’s position across the spectrum of clinical quality control tools market
26 November 2018Blog - From our origins testing tobacco, alcohol and food products for adulteration in the 19thcentury, LGC has built a commitment to using science for a safer world.
12 February 2018Blog - Pharmacogenetics, or the study of how people respond differently to medicines due to their genetics, is making a splash lately thanks to companies like Minneapolis, MN-based OneOme, which co-developed its RightMed test with Mayo Clinic
11 July 2018